[Molecular epidemiology of pneumococci with decreased susceptibility to penicillin isolated in a Parisian pediatric hospital]. 1996

D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
Service de Microbiologie, Hôpital d'Enfants Armand-Trousseau, Paris, France.

Pneumococci with decreased susceptibility or resistant to penicillin (PRP) have been isolated with an increasing frequency in France. Among PRP, isolates of serotypes 23F and 9V were the most frequently recovered in our children's hospital. Penicillin-resistance is due to the appearance of altered penicillin binding proteins (PBPs) with reduced affinity for beta-lactam antibiotics. 3 PBPs have been well studied, 2b, 2x and 1a, and the sequences of their genes have been determined. Our molecular epidemiological study of 14 PRP 9V and 26 PRP 23F isolated mainly from otitis in 1993-94, consisted of determining chromosomic restriction patterns (Apa I) by pulsed-field gel electrophoresis, and restriction patterns (Hinf I) of PBP genes pbp 2b, pbp 2x and pbp 1a after PCR. All the PRP 9V exhibited the same pulsotype and identical patterns for each of the genes pbp 2b, pbp 2x and pbp 1a, suggesting a clonal origin. The origins of PRP 23F were more heterogenous: 5 clones could be defined, with one predominant clone composed of 20 isolates. Most of the PRP 23F shared identical profiles for the genes pbp 2b, pbp 2x and pbp 1a with the PRP 9V, suggesting a horizontal transfer of DNA. Molecular markers, which provide more informations than serotyping, were useful to clarify the complex epidemiology of PRP.

UI MeSH Term Description Entries
D010035 Otitis Media, Suppurative Inflammation of the middle ear with purulent discharge. Otitis Media, Purulent,Purulent Otitis Media,Suppurative Otitis Media
D010297 Paris The capital city of France.
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D006776 Hospitals, Pediatric Special hospitals which provide care for ill children. Pediatric Hospitals,Hospital, Pediatric,Pediatric Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
January 1997, Journal of clinical microbiology,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
October 1993, Infection and immunity,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
January 1986, Annales de l'Institut Pasteur. Microbiologie,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
January 1995, Scandinavian journal of infectious diseases,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
September 1992, The Journal of antimicrobial chemotherapy,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
January 1994, Scandinavian journal of infectious diseases,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
March 1980, Journal of clinical microbiology,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
January 1998, Therapeutische Umschau. Revue therapeutique,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
February 2001, Journal of clinical microbiology,
D Moissenet, and L Guet, and M Valcin, and E N Garabedian, and P Geslin, and A Garbarg-Chenon, and H Vu-Thien
April 1996, Nordisk medicin,
Copied contents to your clipboard!